# DHM Drug Interactions - Quick Reference Guide

**Last Updated:** 2025-11-09

---

## ğŸš« ABSOLUTE CONTRAINDICATIONS (DO NOT USE)

| Contraindication | Reason | Evidence |
|-----------------|--------|----------|
| **Pregnancy** | Unknown effects on fetus, insufficient safety data | No human studies |
| **Breastfeeding** | May pass into breast milk, effects unknown | No lactation studies |
| **Children <18** | Lack of pediatric safety data | Not studied in children |
| **Phenylketonuria (PKU)** | May contain phenylalanine | Metabolic disorder risk |

---

## âš ï¸ HIGH CAUTION - MANDATORY PHYSICIAN CONSULTATION

| Drug/Condition | Risk Level | Concern | Evidence | Action Required |
|----------------|------------|---------|----------|-----------------|
| **Blood Thinners** | HIGH | Additive antiplatelet effects, bleeding risk | Moderate (animal) | Consult MD, monitor bleeding |
| **Chemotherapy** | HIGH | Alters drug sensitivity/resistance | Strong (in vitro) | **Oncologist approval mandatory** |
| **Transplant Drugs** | HIGH | May alter immunosuppressant levels (CYP3A4) | Weak (theoretical) | **Transplant team approval mandatory** |
| **Pre-Surgery** | HIGH | Bleeding risk | Theoretical | **Stop 14 days before surgery** |
| **Bleeding Disorders** | HIGH | Worsening bleeding | Theoretical | **Hematologist consult required** |

---

## âš¡ MODERATE CAUTION - INFORM PHYSICIAN & MONITOR

| Drug Class | Specific Medications | Risk Level | Concern | Monitoring Needed |
|------------|---------------------|------------|---------|-------------------|
| **Diabetes Meds** | Insulin, metformin, sulfonylureas | MODERATE | Additive glucose-lowering, hypoglycemia risk | Blood glucose monitoring |
| **Sedatives/Benzos** | Diazepam, lorazepam, alprazolam, zolpidem | MODERATE-HIGH | GABA-A receptor interaction | Sedation effects, dose monitoring |
| **Statins (CYP3A4)** | Atorvastatin, simvastatin, lovastatin | MODERATE | Potential increased statin levels | Muscle pain, liver enzymes |

---

## â„¹ï¸ LOW CAUTION - INFORM PHYSICIAN

| Drug/Condition | Risk Level | Evidence | Recommendation |
|----------------|------------|----------|----------------|
| **Blood Pressure Meds** | LOW | DHM doesn't affect BP in animals | Monitor BP when starting |
| **Antibiotics (most)** | LOW | Fluconazole study showed no interaction | Generally safe |
| **Liver Disease** | LOW | DHM is hepatoprotective, not toxic | Consult hepatologist if advanced |
| **Kidney Disease** | LOW | DHM is renoprotective | Consult nephrologist if severe |
| **Autoimmune Disease** | LOW-MODERATE | Anti-inflammatory, may help RA | Inform rheumatologist |

---

## â“ UNKNOWN - NO DATA AVAILABLE

| Drug Class | Evidence | Recommendation |
|------------|----------|----------------|
| **Antidepressants** (SSRIs, MAOIs, SNRIs) | None | Consult psychiatrist; unknown risk |
| **Thyroid Medications** (Levothyroxine) | None | Separate by 4 hours; monitor levels |
| **Many others** | Insufficient | Always inform your doctor |

---

## ğŸ“Š DRUG INTERACTION SEVERITY TABLE

| Drug/Class | Evidence Quality | Interaction Severity | Clinical Studies | Action |
|------------|------------------|---------------------|------------------|--------|
| **Warfarin/Blood Thinners** | Moderate (animal) | âš ï¸âš ï¸âš ï¸ HIGH | None | Mandatory MD consult |
| **Chemotherapy** | Strong (in vitro) | âš ï¸âš ï¸âš ï¸ HIGH | Multiple animal | Oncologist approval |
| **Transplant Immunosuppressants** | Weak (theoretical) | âš ï¸âš ï¸âš ï¸ HIGH | None | Transplant team approval |
| **Diabetes Medications** | Moderate (animal + limited human) | âš ï¸âš ï¸ MODERATE | 1-2 human trials | Monitor glucose closely |
| **Benzodiazepines** | Moderate (in vitro + animal) | âš ï¸âš ï¸ MODERATE | None | Consult MD before use |
| **Statins (CYP3A4)** | Weak (theoretical) | âš ï¸ LOW-MODERATE | None | Inform MD, monitor |
| **Blood Pressure Meds** | Weak (animal) | âš ï¸ LOW | None | Monitor BP |
| **Antibiotics/Antifungals** | Moderate (fluconazole rat study) | âš ï¸ LOW | 1 rat study | Generally safe |
| **Antidepressants** | None | â“ UNKNOWN | None | Consult psychiatrist |
| **Thyroid Meds** | None | â“ UNKNOWN | None | Separate dosing, monitor |

---

## ğŸ”¬ MECHANISM OF INTERACTIONS

### CYP450 Enzyme Inhibition
DHM **INHIBITS:**
- CYP3A4 (14.75 Î¼M) - **Many drugs metabolized by this**
- CYP2E1 (25.74 Î¼M)
- CYP2D6 (22.69 Î¼M)

DHM **DOES NOT INHIBIT:**
- CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2C8

**Drugs affected by CYP3A4 inhibition:**
- Statins (atorvastatin, simvastatin)
- Immunosuppressants (tacrolimus, cyclosporine)
- Some chemotherapy drugs
- Benzodiazepines (midazolam, triazolam)
- Many others

### OATP Transporter Inhibition
- **OATP1B1:** Strong inhibition (IC50 1.7-6.4 Î¼M)
- **OATP2B1:** Very strong inhibition (IC50 0.3-0.4 Î¼M)

### GABA-A Receptor Modulation
- Positive modulation at benzodiazepine binding sites
- May interact with sedatives, alcohol, benzodiazepines

### Antiplatelet Effects
- Inhibits platelet activation
- Reduces fibrin generation
- May increase bleeding risk with anticoagulants

---

## ğŸ’Š DOSAGE & SAFETY

### Standard Doses:
- **Hangover prevention:** 100-600 mg (before alcohol)
- **Hangover relief:** 100-200 mg (after drinking)
- **General supplementation:** 300-1000 mg daily
- **Clinical trials:** 150-600 mg daily

### Safety Profile:
- âœ… **Minimal adverse events** in clinical trials
- âœ… **No liver toxicity** (LiverTox database)
- âœ… **Very low toxicity** in animals (>10 g/kg)
- âœ… Mild GI upset rare

### Common Side Effects (Rare):
- Nausea (mild, self-limiting)
- Diarrhea (infrequent)
- Abdominal discomfort (rare)

---

## ğŸ©º MEDICAL CONDITIONS - SAFETY SUMMARY

| Condition | Safety | Evidence | Action |
|-----------|--------|----------|--------|
| **Liver Disease** | âœ… Likely SAFE | Hepatoprotective studies | Consult if advanced cirrhosis |
| **Kidney Disease** | âœ… Likely SAFE | Renoprotective studies | Consult if on dialysis |
| **Diabetes** | âš ï¸ CAUTION | Lowers blood sugar | Monitor glucose; may reduce med needs |
| **Heart Disease** | â„¹ï¸ INFORM MD | Cardioprotective effects | Generally beneficial |
| **Autoimmune Disease** | â„¹ï¸ INFORM MD | Anti-inflammatory | May help RA; inform rheumatologist |
| **Pregnancy** | ğŸš« AVOID | No safety data | Contraindicated |
| **Breastfeeding** | ğŸš« AVOID | No safety data | Contraindicated |

---

## ğŸº ALCOHOL INTERACTION

**âœ… SAFE - This is DHM's primary studied use**

- DHM is **designed** for use with alcohol
- Reduces alcohol intoxication symptoms
- Protective against liver injury
- Reduces hangover severity
- Works via GABA-A modulation (not just metabolism)

**Note:** Recent evidence suggests DHM does NOT speed up alcohol metabolism but protects the brain and liver.

---

## ğŸ“‹ PRE-SURGERY CHECKLIST

### 14 Days Before Surgery:
- [ ] **STOP DHM** (bleeding risk)
- [ ] Inform surgeon you've been taking DHM
- [ ] Inform anesthesiologist
- [ ] List DHM on pre-op medication form

### After Surgery:
- [ ] Wait until surgical wounds heal
- [ ] Consult surgeon before resuming
- [ ] May resume after clearance

---

## ğŸ” WHEN TO SEEK MEDICAL ADVICE

**Consult your doctor BEFORE taking DHM if you:**
1. Take ANY prescription medications
2. Have any chronic medical conditions
3. Are pregnant, trying to conceive, or breastfeeding
4. Are under 18 years old
5. Have had an organ transplant
6. Have a bleeding disorder
7. Are scheduled for surgery within 2 weeks
8. Have PKU or metabolic disorders

**Seek IMMEDIATE medical attention if you experience:**
- Unusual bleeding or bruising
- Signs of low blood sugar (if diabetic)
- Severe abdominal pain
- Allergic reaction (rash, difficulty breathing)
- Any concerning symptoms

---

## ğŸ¯ DECISION TREE: Should I Take DHM?

```
START
  â†“
Are you pregnant/breastfeeding/under 18?
  YES â†’ âŒ DO NOT TAKE DHM
  NO â†’ Continue
  â†“
Do you have organ transplant?
  YES â†’ âŒ DO NOT TAKE without transplant team approval
  NO â†’ Continue
  â†“
Are you on blood thinners or having surgery within 14 days?
  YES â†’ âš ï¸ MANDATORY doctor consultation
  NO â†’ Continue
  â†“
Are you on chemotherapy?
  YES â†’ âš ï¸ MANDATORY oncologist approval
  NO â†’ Continue
  â†“
Do you take diabetes meds, benzos, or sedatives?
  YES â†’ âš ï¸ Consult doctor, monitor closely
  NO â†’ Continue
  â†“
Do you take ANY prescription medications?
  YES â†’ â„¹ï¸ Inform your doctor
  NO â†’ âœ… Generally safe (start with low dose)
```

---

## ğŸ“š KEY RESEARCH CITATIONS

- **CYP450 interactions:** PMID 28614988
- **Antiplatelet effects:** PMID 33711433
- **Diabetes/metformin synergy:** ScienceDirect 2023
- **GABA modulation:** PMID 22219299
- **Liver safety:** LiverTox NBK594407
- **Chemotherapy synergy:** PMID 25915649, 28436480
- **Clinical trials:** NCT03606694 (diabetes), NCT05623501 (dose escalation)

---

## âš ï¸ DISCLAIMER

**This is NOT medical advice.**

- Information based on research as of 2025-11-09
- Most data from animal/in vitro studies (limited human data)
- Individual responses vary
- **ALWAYS consult your healthcare provider** before taking DHM
- Especially critical if you take medications or have medical conditions

**When in doubt, ask your doctor.**

---

## ğŸ”„ Evidence Quality Legend

| Symbol | Meaning | Basis |
|--------|---------|-------|
| âœ… | Safe/Well-studied | Multiple human studies |
| âš ï¸ | Caution needed | Animal studies, in vitro data, theoretical |
| âš ï¸âš ï¸ | Moderate caution | Animal studies + biological plausibility |
| âš ï¸âš ï¸âš ï¸ | High caution/avoid | Strong theoretical concern or known interaction |
| â“ | Unknown | No data available |
| ğŸš« | Contraindicated | Avoid - insufficient safety data |
| â„¹ï¸ | Inform physician | Low risk but worth mentioning |

---

**ğŸ“ In Case of Emergency:** If you experience a serious adverse reaction to DHM, seek immediate medical attention and report it to:
- Your healthcare provider
- FDA MedWatch: 1-800-FDA-1088
- Poison Control: 1-800-222-1222

---

**Version:** 1.0
**Last Updated:** 2025-11-09
**Based on:** Comprehensive literature review of PubMed, clinical trials databases, and safety resources
